While 2020 is an incredible and very difficult year, it has also been a year of remarkable biopharmaceutical accomplishments. Developments from vaccine development to new models of pharmaceutical R&D have transformed the biopharmaceutical industry. Here, we review the top five trends that have impacted the biopharma industry in the last year and that will continue to influence the industry in 2021 and long beyond.
Bayer ag announced the acquisition of Vividion, a biopharmaceutical company based in the United States. The company uses new discovery techniques to develop precision therapies by unlocking high-value targets that have not traditionally been available over the counter. Vividion's platform enables a range of small molecule therapies for a wide range of indications, initially focusing on oncology and immunology related targets. Vividion's focus includes multiple precision oncology targets as well as precision immunology targets.
Pharmaceutical companies can be a great investment. Especially for investors in search of long-term growth candidates for their portfolio. A successful new drug or treatment is covered by patents for 20 years in the U.S. market.
Research-based biopharmaceutical multinational AstraZeneca, one of the earliest healthcare companies to enter the Taiwan market, has been working to deliver the best in patient care in Taiwan for over 70 years.
The Chinese pharmaceutical company Shanghai Pharmaceuticals Holding Co. has acquired 100% of the share capital of the Finnish dental equipment manufacturer Fimet Oy along with its operations in Finland and China, Helsinki Times reports.
The Importance of Weight Loss and Exercise.Carrying around too much weight feels uncomfortable, and it can also damage your health. According the Centers of Disease Control and PreventionTrusted Source (CDC), obesity rates have skyrocketed in the United States in recent years.